Tag: Prescription Drugs
Dersimelagon Beneficial for Erythropoietic, X-Linked Protoporphyria
Dersimelagon at doses of 100 and 300 mg increases duration of symptom-free sunlight exposure versus placebo
Prophylactic Use of Tranexamic Acid Not Beneficial in Cesarean Delivery
Risk for composite outcome of maternal death or blood transfusion no lower with tranexamic acid versus placebo
Appeals Court Keeps Abortion Pill Available, With Restrictions
Three-member panel partially overruled Judge Matthew Kacsmaryk's ruling in Texas last week
Guideline Updated for Initial Management of Advanced Prostate Cancer
Triplet therapy should be offered to patients with de novo metastatic noncastrate prostate cancer with high-volume disease
Justice Department Appeals Texas Judge’s Ruling on Abortion Pill
Texas judge alleges that the FDA should not have approved mifepristone because it did not adequately review its safety risks
Anakinra Does Not Prevent Mechanical Ventilation in Severe COVID-19 Pneumonia
However, authors say anakinra may have a role as early treatment for patients with less severe COVID-19
Judge’s Challenge to Abortion Pill Access Brings Swift Reaction
Two opposing rulings are setting the stage for a Supreme Court showdown on the safety of mifepristone
FDA Withdraws Approval of Drug Meant to Prevent Preterm Births
Agency has formally withdrawn the approval of Makena over a lack of effectiveness and serious side effects that include blood clots, depression
Emergency Department-Administered Buprenorphine Is Safe, Effective
Rates of precipitated withdrawal are less than 1 percent
Early mAb Treatment Beneficial for Outpatients With COVID-19
Reduced risk of hospitalization or death seen at 28 days; lower risk seen for all individual mAb products
